No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs545481015 |
chr12:63270292-63270293 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs565188399 |
chr12:63270314-63270315 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs187540067 |
chr12:63270315-63270316 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs547441795 |
chr12:63270321-63270322 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs11174704 |
chr12:63270324-63270325 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs7296423 |
chr12:63270329-63270330 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs192777572 |
chr12:63270374-63270375 |
Weak transcription Bivalent Enhancer Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs146041757 |
chr12:63270422-63270423 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs139251372 |
chr12:63270442-63270443 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs12823199 |
chr12:63270447-63270448 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs571217401 |
chr12:63270502-63270503 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs185554257 |
chr12:63270504-63270505 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs149971002 |
chr12:63270521-63270522 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs369946712 |
chr12:63270566-63270567 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs574028173 |
chr12:63270568-63270569 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs145198955 |
chr12:63270594-63270595 |
Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs556386042 |
chr12:63270601-63270602 |
Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|